Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kevin Muszynski"'
Autor:
Darrick T. Balu, Harry Pantazopoulos, Cathy C.Y. Huang, Kevin Muszynski, Theresa Lynn Harvey, Yota Uno, Jacki M. Rorabaugh, Claire R. Galloway, Christian Botz-Zapp, Sabina Berretta, David Weinshenker, Joseph T. Coyle
Publikováno v:
Neurobiology of Disease, Vol 130, Iss , Pp 104511- (2019)
Although β-amyloid plaques are a well-recognized hallmark of Alzheimer's disease (AD) neuropathology, no drugs reducing amyloid burden have shown efficacy in clinical trials, suggesting that once AD symptoms emerge, disease progression becomes indep
Externí odkaz:
https://doaj.org/article/1a5c97093b8940d89bd516ac40a6131c
Publikováno v:
Translational Psychiatry, Vol 9, Iss 1, Pp 1-15 (2019)
Translational Psychiatry
Translational Psychiatry
Schizophrenia is a severe and highly heritable disorder. Dystrobrevin-binding protein 1 (DTNBP1), also known as dysbindin-1, has been implicated in the pathophysiology of schizophrenia. Specifically, dysbindin-1 mRNA and protein expression are decrea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38895e6ffdc012752b8d9c8c16bb3f1a
http://link.springer.com/article/10.1038/s41398-019-0465-y
http://link.springer.com/article/10.1038/s41398-019-0465-y
Autor:
Kevin Muszynski, Kerry J. Ressler, Joseph T. Coyle, Kendall Taylor Presti, Inna Radzishevsky, Darrick T. Balu, Cathy C.Y. Huang, Herman Wolosker, Guia Guffanti
Publikováno v:
Biological Psychiatry. 83:273-283
Background The amygdala is a central component of the neural circuitry that underlies fear learning. N-methyl-D-aspartate receptor–dependent plasticity in the amygdala is required for pavlovian fear conditioning and extinction. N-methyl-D-aspartate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c9c383a505f07463d74afb12d850103
https://doi.org/10.1016/j.biopsych.2017.08.012
https://doi.org/10.1016/j.biopsych.2017.08.012
Autor:
Theresa L. Harvey, Joseph T. Coyle, Kevin Muszynski, Claire R. Galloway, Harry Pantazopoulos, Cathy C.Y. Huang, Yota Uno, Christian A. Botz-Zapp, Sabina Berretta, Jacki M. Rorabaugh, David Weinshenker, Darrick T. Balu
Publikováno v:
Neurobiol Dis
Neurobiology of Disease, Vol 130, Iss, Pp 104511-(2019)
Neurobiology of Disease, Vol 130, Iss, Pp 104511-(2019)
Although β-amyloid plaques are a well-recognized hallmark of Alzheimer's disease (AD) neuropathology, no drugs reducing amyloid burden have shown efficacy in clinical trials, suggesting that once AD symptoms emerge, disease progression becomes indep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::858b5bff250d09a080bcb33c7a6148da
https://europepmc.org/articles/PMC6689433/
https://europepmc.org/articles/PMC6689433/
